The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome

Journal of Diabetes and its Complications

Volumn 11, Issue 2, 1997, Pages 60-68

  Zimmet, Paul Z ^a   McCarty, Daniel J ^a   De Courten, Maximilian P ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LEPTIN;

ADULT; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; DEVELOPED COUNTRY; ENVIRONMENTAL FACTOR; EPIDEMIC; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEREDITY; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIFESTYLE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; POPULATION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SOCIOECONOMICS;

DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL HEALTH; FEMALE; HUMANS; INDIAN OCEAN ISLANDS; MALE; MIDDLE AGED; PACIFIC ISLANDS; PHENOTYPE; PREVALENCE; SOCIOECONOMIC FACTORS; SYNDROME;

EID: 0030896748     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00090-6     Document Type: Article

References (47)

1. McCarty D, Zimmet P: Diabetes 1994 to 2010: Global Estimates and Projections. Melbourne, International Diabetes Institute, 1994.
2. World Health Organization (WHO): Prevention of Diabetes Mellitus, Geneva, Technical Report Series no. 844, 1994.
3. Songer T: The economic costs of NIDDM. Diabetes Metab Rev 8:389-404, 1992.
4. Hennekens GH, Buring JE: Epidemiology in Medicine. Boston, Little, Brown and Company, 1987.
5. Zimmet P: Challenges in diabetes epidemiology-From West to the rest. Diabetes Care 15:232-252, 1992.
6. Zimmet P: Non-insulin-dependent (type 2) diabetes mellitus - Does it really exist? Diabetic Med 6:728-738, 1989.
7. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
8. Kaplan MM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridaemia, and hypertension. Arch Intern Med 149:1514-1520, 1989.
9. Zimmet P, Dowse G, Serjeantson S, Finch C, King H: The epidemiology and natural history of NIDDM-Lessons from the South Pacific. Diabetes Metab Rev 6:91-124, 1990.
10. King H, Rewers M: WHO Ad Hoc Diabetes Reporting Group: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157-177, 1993.
11. Bennett PH, Bogardus C, Tuomilehto J, Zimmet P: Epidemiology and natural history of NIDDM: Non-obese and obese, in Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds), International Textbook of Diabetes Mellitus. London, John Wiley, 1992, pp. 147-176.
12. Humphrey ARG, Zimmet PZ, Hamman RF: The epidemiology of diabetes mellitus. Diabetes Annu 9:1-31, 1995.
13. Dowse GK, Spark RA, Mavo B, Hodge AM, Erasmus RT, Gwalimu M, Knight LT, Koki G, Zimmet PZ: Extraordinary prevalence of non-insulin-dependent diabetes mellitus and biomodal plasma glucose distribution in the Wanigela people of Papua New Guinea. Med ] Australia 160:767-774, 1994.
14. Zimmet P: Diabetes care and prevention-Around the world in 80 days, in Rifkin H, Colwell JA, Taylor SI (eds), Diabetes 1991. New York, Elsevier, 1991, pp. 721-729.
15. Dowse GK, Gareeboo H, Zimmet PZ, Alberti KGGM, Tuomilehto J, Fareed D, Brissonnette LG, Finch CF: High prevalence of NIDDM and impaired glucose intolerance in Indian, Creole and Chinese Mauritians. Diabetes 39:390-396, 1990.
16. Zimmet P: The pathogenesis and prevention of diabetes in adults: Genes, autoimmunity and demography. Diabetes Care 18:1050-1064, 1995.
17. McCarthy MI, Froguel P, Hitman GA: The genetics of non-insulin-dependent diabetes mellitus: Tools and aims. Diabetologia 37:959-968, 1994.
18. Hamman RF: Genetic and environmental determinants of non-insulin dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8:287-338, 1993.
19. Dowse GK, Zimmet PZ, Gareeboo H, Alberti KGMM, Tuomilehto }, Finch CF, Chitson P, Tulsidas H: Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole and Chinese Mauritians. Diabetes Care 14:271-282, 1991.
20. Tuomilehto J, Knowler WC, Zimmet P: Primary prevention of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 8:339-353, 1992.
21. Zimmet P: Hyperinsulinaemia - How innocent a bystander. Diabetes Care 16:56-70, 1993.
22. Hales CM, Barker DJP: Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 35:595-601, 1992.
23. McCance DR, Pettit DJ, Hanson RL, Jacobsson LTH, Knowler WC, Bennett PH: Birth weight and non-insulin dependent diabetes: Thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ 308:942-945, 1994.
24. Waldhäusl W, Fasching P: Fetal growth and impaired glucose tolerance in men and women. Diabetologia 36:973-974, 1993.
25. Finch CF, Zimmet PZ: Mortality from diabetes, in Alberti KGMM, Krall LP (eds), The Diabetes Annual/4. Amsterdam, Elsevier, 1988, pp. 1-16.
26. Panzram G: Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:123-131, 1987.
27. Jarrett RJ: Epidemiology of macrovascular disease and hypertension in diabetes mellitus, in Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds), International Textbook of Diabetes Mellitus. John Wiley and Sons, 1992, pp. 1459-1470.
28. Klein R, Moss SE: Visual impairment and diabetes, in Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds), International Textbook of Diabetes Mellitus. John Wiley and Sons, 1992, pp. 1373-1384.
29. Viberti GC, Walker JD, Pinto JD: Diabetic nephropathy, in Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds), International Textbook of Diabetes Mellitus, John Wiley and Sons, 1992, pp. 1267-1328.
30. Ward JD: Diabetic neuropathy, in Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds), International Textbook of Diabetes Mellitus. John Wiley and Sons, 1992, pp. 1385-1414.
31. Vaughan P, Gilson L, Mills A: Diabetes in developing countries: Its importance for public health. Health Policy Planning 4:97-109, 1989.
32. Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15:815-819, 1992.
33. Collins VR, Dowse GK, Finch CF, Zimmet PZ: An inconsistent relationship between insulin and blood pressure in three Pacific island populations. J Clin Epidemiol 43:1369-1378, 1990.
34. De Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti G: Hyperleptinaemia: the missing link in the Metabolic Syndrome? Diabetic Medicine 1997 (in press).
35. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset on clinical diabetes? JAMA 263:2893-2898, 1990.
36. Neel JV: Diabetes mellitus: a thrifty genotype rendered detrimental by 'progress'? Am J Hum Genetics 14:353-362, 1962.
37. Dowse G, Zimmet P: Editorial. The thrifty genotype in non-insulin-dependent diabetes. The hypothesis survives. BMJ 306:532-533, 1993.
38. Zimmet P, O'Dea K: Thrifty genotype, in Leslie RD (ed), Causes of Diabetes, London, John Wiley and Sons, 1993, pp. 269-290.
39. Zimmet P, Collier G: Of mice and (wo)men: the obesity (ob) gene, its product, leptin and obesity, Med J Aust 164:393-394, 1996.
40. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995.
41. Zimmet P. Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Morawieczki A, Lubina J, Collier G, Alberti G, Dowse G: Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. B M J 313:965-969.
42. Collins VR, Dowse GK, Toelupe P, Imo T, Aloaina F, Spark RA, Zimmet PZ: Increasing prevalence of NIDDM in the Pacific island population of Western Samoa over a 13-year period. Diabetes Care 17:288-296, 1994.
43. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995.
44. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995.
45. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161, 1995.
46. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996.
47. Collier G, Walder K, Lewandowski P, Sanigorski A, Zimmet P: Does the 'thrifty gene' cause leptin resistance? Diabetes 1997, (in press).